CREB, a transcription factor crucial for neuronal plasticity and survival, and autophagy, a cellular degradation pathway important for clearing misfolded proteins, represent potential targets through which TAC could exert neuroprotective effects and mitigate the accumulation of Aβ and pathological tau proteins, which are hallmark features of AD [12,13,14]. This evidence concerns the gene MAPT and Alzheimer disease.